IMUGENE LIMITED — Capital/Financing Update 2022

Sep 11, 2022

Market Announcement

==> picture [33 x 50] intentionally omitted <==

12 September 2022

==> picture [451 x 5] intentionally omitted <==

Imugene Limited (ASX: IMU) – Trading Halt

Description

The securities of Imugene Limited (‘IMU’) will be placed in trading halt at the request of IMU, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 14 September 2022 or when the announcement is released to the market.

Issued by

Melissa Kostopoulos

Compliance Adviser, Listings Compliance (Melbourne)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

12 September 2022 ASX Limited

==> picture [177 x 30] intentionally omitted <==

Suite 12.01, Level 12 4-6 Bligh Street Sydney NSW 2000 www.imugene.com ABN: 99 009 179 551 Phone: +61 3 9824 5254

12 September 2022

Melissa Kostopoulos Compliance Adviser, Listings Compliance (Melbourne) ASX Compliance Pty Ltd 525 Collins Street, Melbourne, VIC. 3000

Via email: TradingHaltsMelbourne@asx.com.au

Dear Melissa

Imugene Limited (ASX: IMU) TRADING HALT REQUEST

In accordance with ASX Listing Rule 17.1, Imugene Limited (ASX: IMU) (the Company ) hereby requests that its securities be placed in a trading halt. The trading halt is requested for the purposes of a planned capital raising to facilitate investment from two new institutional investors.

The Company requests that trading in its securities be halted until after the expected announcement is made or until the market opens on Wednesday, 14 September 2022, whichever is the earlier.

The Company is not aware of any reason why this trading halt request should not be granted.

Please contact me if you require any further information.

Yours sincerely

==> picture [58 x 44] intentionally omitted <==

Phillip Hains Company Secretary Imugene Limited

info@imugene.com

IMUGENE LIMITED ACN 009 179 551

WWW.IMUGENE.COM